This afternoon, the Pennsylvania State House passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.
This afternoon, the New York State Senate passed legislation that would eliminate cost-sharing for lung cancer screenings and follow-up tests. Senate Bill 8553-A received bipartisan support for the proposal impacting all payers in New York, including Medicaid.
Today, the American Cancer Society Cancer Action Network was joined by 51 other organizations in a letter asking Congress to swiftly pass the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act.
Dr. Cheasty Anderson has joined the American Cancer Society Cancer Action Network (ACS CAN) as the managing director for the Gulf Coast Region, which includes Alabama, Arkansas, Louisiana, Mississippi, Oklahoma, Tennessee, and Texas. In this role, Anderson will lead ACS CAN’s staff and volunteers in each state as they work to advance legislation and public policies to reduce cancer.
Governor Jared Polis signed SB24-124 into law during a ceremony at the Governor’s Mansion on Monday afternoon, ensuring more Colorado patients with private insurance have coverage for biomarker testing. The American Cancer Society Cancer Action Network (ACS CAN) recognizes the signing of the bill as a positive first step to increasing access to biomarker testing to connect patients with the right treatment at the right time. During Monday’s ceremony, Governor Polis was surrounded by advocates from ACS CAN including cancer survivors, as well as bill sponsors Sen. Dafna Michaelson Jenet, Rep. Anthony Hartsook, and Rep. Monica Duran.
Today, the House Insurance Committee voted to improve Pennsylvanians’ access to biomarker testing, advancing House Bill 1754 out of committee unanimously. Championed by Representatives Kyle Mullins and Minority Leader Bryan Cutler, the proposal would ensure biomarker testing is a covered benefit in Pennsylvania-regulated insurance plans, including Medicaid, when medical and scientific evidence shows it would provide a benefit to patients. Advocates now look to the full House to favorably advance House Bill 1754 to the Senate.
Gov. Ned Lamont has signed into law S.B. 307 An Act Concerning Medicaid Coverage of Biomarker Testing. This legislation will increase Connecticut Medicaid (HUSKY Health) coverage of biomarker testing, a form of precision medicine that enables patients to receive treatments personalized to their specific disease.
NASHVILLE, Tenn. – Gov. Bill Lee signed HB 2954/SB2883 this week, making Tennessee the sixth state in the U.S. to enhance coverage of prostate cancer screenings for high-risk men.
S. 689 & H. 1074 would ensure all communities benefit from the same advances in medical treatment through biomarker testing
ACS CAN released two reports today which provide a snapshot of utilization management requirements for specific cancer drugs in both the Medicare Part D plans and Medicare Advantage plans with drug coverage.